Drug-Eluting Stent DRGs Sustained At FY 2003 Rates – IPPS Final Rule
This article was originally published in The Gray Sheet
Executive Summary
CMS will maintain the current DRG weights for drug-eluting stents in FY 2004, contending it is not "appropriate" to use anticipated Oct. 1 charges to set payment rates, according to the hospital 1IPPS final rule
You may also be interested in...
CMS Criteria For Accepting External Data Should Be Clarified – AdvaMed
CMS should accept external data carrying a time lag of only 60 to 90 days when determining payments for new technologies assigned to the inpatient or outpatient payment systems, according to AdvaMed
CMS Criteria For Accepting External Data Should Be Clarified – AdvaMed
CMS should accept external data carrying a time lag of only 60 to 90 days when determining payments for new technologies assigned to the inpatient or outpatient payment systems, according to AdvaMed
Drug-Eluting Stent Payment Should Reflect Patient Complexity – Task Force
CMS should create differential drug-eluting stent DRG payment rates based on patient complexity to ensure adequate hospital reimbursement, a Society for Cardiovascular Angiography & Interventions task force report advises